Real-world experience of immune checkpoint inhibitors in MSI-H/dMMR metastatic colorectal cancer in a tertiary cancer center in Saudi Arabia

被引：0
|
作者：
Ajina, R. [1 ]
Alhareeri, A. [1 ]
Philip, W. [1 ]
Alsekait, N. [2 ]
Alarifi, N. [2 ]
Alismail, H. [1 ]
Alshieban, S. [3 ]
Almuzzaini, B. [4 ]
Alshammari, K. [5 ]
机构：
[1] King Saud bin Abdulaziz Univ Hlth Sci, KAIMRC, Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia
[2] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia
[3] King Saud bin Abdulaziz Univ Hlth Sci, King Abdulaziz Med City, KAIMRC, Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia
[4] KSAU HS, King Abdullah Int Med Res Ctr, Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia
[5] Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.04.344
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-288
引用
收藏
页码：S117 / S117
页数：1
相关论文
共 50 条
  • [1] Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience
    Higbie, Victoria Serpas
    Rogers, Jane
    Hwang, Hyunsoo
    Qiao, Wei
    Xiao, Lianchun
    Dasari, Arvind
    Mola-Rudd, Kerri
    Morris, Van K.
    Wolff, Robert A.
    Raghav, Kanwal
    Huey, Ryan
    Parseghian, Christine
    Willis, Jason
    Kopetz, Scott
    Overman, Michael J.
    Johnson, Benny
    [J]. ONCOLOGIST, 2022, 27 (11): : 952 - 957
  • [2] Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer
    Nasca, Vincenzo
    Barretta, Francesco
    Corti, Francesca
    Lonardi, Sara
    Niger, Monica
    Elez, Maria Elena
    Fakih, Marwan
    Jayachandran, Priya
    Shah, Aakash Tushar
    Salati, Massimiliano
    Fenocchio, Elisabetta
    Salvatore, Lisa
    Cremolini, Chiara
    Ros, Javier
    Ambrosini, Margherita
    Mazzoli, Giacomo
    Intini, Rossana
    Overman, Michael J.
    Miceli, Rosalba
    Pietrantonio, Filippo
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (02)
  • [3] Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer
    Nasca, Vincenzo
    Barretta, Francesco
    Corti, Francesca
    Lonardi, Sara
    Niger, Monica
    Elez, Maria Elena
    Fakih, Marwan
    Jayachandran, Priya
    Shah, Aakash Tushar
    Salati, Massimiliano
    Fenocchio, Elisabetta
    Salvatore, Lisa
    Cremolini, Chiara
    Ros, Javier
    Ambrosini, Margherita
    Mazzoli, Giacomo
    Intini, Rossana
    Overman, Michael J.
    Miceli, Rosalba
    Pietrantonio, Filippo
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (01)
  • [4] Immunotherapy Promising for Metastatic MSI-H/dMMR Colorectal Cancer
    Yarden, Ronit
    [J]. ONCOLOGY-NEW YORK, 2019, 33 (05): : 179 - 179
  • [5] Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer
    Bui, Quang Loc
    Mas, Leo
    Hollebecque, Antoine
    Tougeron, David
    de la Fouchardiere, Christelle
    Pudlarz, Thomas
    Alouani, Emily
    Guimbaud, Rosine
    Taieb, Julien
    Andre, Thierry
    Colle, Raphael
    Cohen, Romain
    [J]. CANCERS, 2022, 14 (02)
  • [6] Real-world safety experience with immune checkpoint inhibitors in Saudi Arabia
    Al Nuhait, Mohammed
    Bajnaid, Eshtyag
    Al Otaibi, Abdulmalik
    Al Shammari, Abdullah
    Al Awlah, Yousef
    [J]. SCIENCE PROGRESS, 2021, 104 (01)
  • [7] Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients
    Margalit, Ofer
    Stemmer, Amos
    Chapin, William J.
    Shacham-Shmueli, Einat
    Kopetz, Scott
    Andre, Thierry
    Overman, Michael J.
    Pietrantonio, Filippo
    Boursi, Ben
    [J]. EUROPEAN JOURNAL OF CANCER, 2024, 212
  • [8] Real-world treatment patterns and unmet need in patients with previously treated metastatic colorectal cancer that is not MSI-H or dMMR.
    Desai, Kaushal
    Sura, Sneha
    Liu, Zhimei
    Amonkar, Mayur
    Jain, Rishi
    Niehoff, Nicole
    Wilson, Thomas W.
    Patton, Gregory A.
    Cosgrove, David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 53 - 53
  • [9] Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers
    Fuca, Giovanni
    Cohen, Romain
    Lonardi, Sara
    Shitara, Kohei
    Elena Elez, Maria
    Fakih, Marwan
    Chao, Joseph
    Klempner, Samuel J.
    Emmett, Matthew
    Jayachandran, Priya
    Bergamo, Francesca
    Diez Garcia, Marc
    Mazzoli, Giacomo
    Provenzano, Leonardo
    Colle, Raphael
    Svrcek, Magali
    Ambrosini, Margherita
    Randon, Giovanni
    Shah, Aakash Tushar
    Salati, Massimiliano
    Fenocchio, Elisabetta
    Salvatore, Lisa
    Chida, Keigo
    Kawazoe, Akihito
    Conca, Veronica
    Curigliano, Giuseppe
    Corti, Francesca
    Cremolini, Chiara
    Overman, Michael
    Andre, Thierry
    Pietrantonio, Filippo
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (02)
  • [10] Prognostic impact of performance status on the outcomes of immune checkpoint inhibition strategies in patients with dMMR/MSI-H metastatic colorectal cancer
    Mazzoli, Giacomo
    Cohen, Romain
    Lonardi, Sara
    Corti, Francesca
    Elez, Elena
    Fakih, Marwan
    Jayachandran, Priya
    Colle, Raphael
    Shah, Aakash Tushar
    Salati, Massimiliano
    Fenocchio, Elisabetta
    Salvatore, Lisa
    Ambrosini, Margherita
    Ros, Javier
    Intini, Rossana
    Cremolini, Chiara
    Overman, Michael J.
    Andre, Thierry
    Pietrantonio, Filippo
    [J]. EUROPEAN JOURNAL OF CANCER, 2022, 172 : 171 - 181
12345